Applied DNA Sciences (APDN) Reports In-Line Q3 EPS, beats revenue
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
Depreciation and amortization: 148.53K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Depreciation and amortization: 148.53K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.24), in-line with the analyst estimate of ($0.24). Revenue for the quarter came in at $2.92 million versus the consensus estimate of $2.56 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Melco Resorts & Entertainment (MLCO) Misses Q2 EPS by 7c
- Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
